Artios Pharma: Taking on DNA repair to tackle cancer

2021-11-09 00:00:00

Artios Pharma was formed in 2016 with support from many investors and Cancer Research UK. The company is pioneering therapeutics to target the POLθ DNA repair mechanism in a broad range of cancers, and has now entered first-in-human trials this year.

Read our latest blog post to learn more about the story behind the discovery and its translation.

Notes to editors